Supplementary Table 2 from A Multicenter Phase I Study of Pazopanib in Combination with Paclitaxel in First-Line Treatment of Patients with Advanced Solid Tumors
Year: 2023
Type: supplementary-materials
Abstract: Pharmacokinetic data for a cohort 1 patient with hepatotoxicity dose-limiting toxicity
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362526710
